Skip to main content

Advertisement

SpringerLink
Log in

Rehabilitation of Adult Patients with Primary Brain Tumors

  • Brain Injury Medicine and Rehabilitation (M Segal, Section Editor)
  • Published:
Current Physical Medicine and Rehabilitation Reports Aims and scope Submit manuscript

Abstract

Purpose of Review

To review the medical complications and functional impairments of primary brain tumor survivors and the role of rehabilitation medicine in survivorship care.

Recent Findings

Primary brain tumors share many similar symptoms and functional impairments with stroke and traumatic brain injury. A call for the inclusion of rehabilitation services as part of neuro-oncological care can improve outcomes from patients with PBT to meet the rehabilitative and supportive care needs of the patient with PBT and their caregivers.

Summary

Further studies on the impact of both inpatient and outpatient rehabilitation services are needed to strengthen the evidence and support for rehabilitation medicine.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance

  1. Pace A, Villani V, Parisi C, di Felice S, Lamaro M, Falcicchio C, Bonucci A, Pugliese P, di Napoli A, di Lallo D. Rehabilitation pathways in adult brain tumor patients in the first 12 months of disease. A retrospective analysis of services utilization in 719 patients. Support Care Cancer. 2016;24:4801–6.

    Article  PubMed  Google Scholar 

  2. Fu JB, Morishita S, Yadav R. Changing paradigms in the rehabilitation of inpatients with brain tumors. Curr Phys Med Rehabil Rep. 2018;6:115–20.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Mukand JA, Blackinton DD, Crincoli MG, Lee JJ, Santos BB. Incidence of neurologic deficits and rehabilitation of patients with brain tumors. Am J Phys Med Rehabil. 2001;80:346–50.

    Article  CAS  PubMed  Google Scholar 

  4. McCartney A, Butler C, Acreman S. Exploring access to rehabilitation services from allied health professionals for patients with primary high-grade brain tumours. Palliat Med. 2011;25:788–96.

    Article  PubMed  Google Scholar 

  5. Mix JM, Granger CV, LaMonte MJ, Niewczyk P, DiVita MA, Goldstein R, Yates JW, Freudenheim JL. Characterization of cancer patients in inpatient rehabilitation facilities: a retrospective cohort study. Arch Phys Med Rehabil. 2017;98:971–80.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Silver JK, Stout NL, Fu JB, Pratt-Chapman M, Haylock PJ, Sharma R. The state of cancer rehabilitation in the United States. J Cancer Rehabil. 2018;1:1–8.

    PubMed  PubMed Central  Google Scholar 

  7. Huang ME, Cifu DX, Keyser-Marcus L. Functional outcomes in patients with brain tumor after inpatient rehabilitation: comparison with traumatic brain injury. Am J Phys Med Rehabil. 79:327–35.

  8. Geler-Kulcu D, Gulsen G, Buyukbaba E, Ozkan D. Functional recovery of patients with brain tumor or acute stroke after rehabilitation: a comparative study. J Clin Neurosci. 2009;16:74–8.

    Article  CAS  PubMed  Google Scholar 

  9. Greenberg E, Treger I, Ring H. Rehabilitation outcomes in patients with brain tumors and acute stroke. Am J Phys Med Rehabil. 2006;85:568–73.

    Article  PubMed  Google Scholar 

  10. Huang ME, Cifu DX, Keyser-Marcus L. Functional outcome after brain tumor and acute stroke: a comparative analysis. Arch Phys Med Rehabil. 1998;79:1386–90.

    Article  CAS  PubMed  Google Scholar 

  11. Siegel RLMKFHJA. Cancer statistics, 2021. CA Cancer J Clin. 2021;71:7–33.

    Article  PubMed  Google Scholar 

  12. Perkins A, Liu G. Primary brain tumors in adults: diagnosis and treatment. Am Fam Physician. 2016;93:211–7.

    PubMed  Google Scholar 

  13. Mohile NA. Medical complications of brain tumors. Continuum. 2017;23:1635–52.

    PubMed  Google Scholar 

  14. Chang SM, Parney IF, Mcdermott M, et al. Perioperative complications and neurological outcomes of first and second craniotomies among patients enrolled in the Glioma Outcome Project. J Neurosurg. 2003;98:1175–81.

    Article  PubMed  Google Scholar 

  15. Deutsch MB, Panageas KS, Lassman AB, DeAngelis LM. Steroid management in newly diagnosed glioblastoma. J Neurooncol. 2013;113:111–6.

    Article  CAS  PubMed  Google Scholar 

  16. Dietrich J, Rao K, Pastorino S, Kesari S. Corticosteroids in brain cancer patients: benefits and pitfalls. Expert Rev Clin Pharmacol. 2011;4:233–42.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Marras LC, Geerts WH, Perry JR. The risk of venous thromboembolism is increased throughout the course of malignant glioma. Cancer. 2000;89:640–6.

    Article  CAS  PubMed  Google Scholar 

  18. Lyman GH, Bohlke K, Khorana AA, et al. Venous thromboembolism prophylaxis and treatment in patients with cancer: American Society of Clinical Oncology clinical practice guideline update 2014. J Clin Oncol. 2015;33:654–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Cramer CK, Cummings TL, Andrews RN, Strowd R, Rapp SR, Shaw EG, Chan MD, Lesser GJ. Treatment of radiation-induced cognitive decline in adult brain tumor patients. Curr Treat Options Oncol. 2019;20:42.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Vargo M. Brain tumor rehabilitation. Am J Phys Med Rehabil. 2011;90:S50–62.

    Article  PubMed  Google Scholar 

  21. Vellayappan B, Tan CL, Yong C, Khor LK, Koh WY, Yeo TT, Detsky J, Lo S, Sahgal A. Diagnosis and management of radiation necrosis in patients with brain metastases. Front Oncol. 2018. https://doi.org/10.3389/fonc.2018.00395.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Thust SC, van den Bent MJ, Smits M. Pseudoprogression of brain tumors. J Magn Reson Imaging. 2018;48:571–89.

    Article  PubMed Central  Google Scholar 

  23. Dietrich J. Neurotoxicity of cancer therapies. Continuum. 2020;26:1646–72.

    PubMed  Google Scholar 

  24. Back M, Back E, Kastelan M, Wheeler H. Cognitive deficits in primary brain tumours: a framework for management and rehabilitation. J Cancer Ther. 2014;05:74–81.

    Article  Google Scholar 

  25. Bergo E, Lombardi G, Pambuku A, dellaPuppa A, Bellu L, D’Avella D, Zagonel V. Cognitive rehabilitation in patients with gliomas and other brain tumors: state of the art. BioMed Res Int. 2016;2016:1–11.

    Article  CAS  Google Scholar 

  26. Gehring K, Patwardhan SY, Collins R, Groves MD, Etzel CJ, Meyers CA, Wefel JS. A randomized trial on the efficacy of methylphenidate and modafinil for improving cognitive functioning and symptoms in patients with a primary brain tumor. J Neurooncol. 2012;107:165–74.

    Article  CAS  PubMed  Google Scholar 

  27. Correa DD, Kryza-Lacombe M, Baser RE, Beal K, DeAngelis LM. Cognitive effects of donepezil therapy in patients with brain tumors: a pilot study. J Neurooncol. 2016;127:313–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Coomans MB, van der Linden SD, Gehring K, Taphoorn MJB. Treatment of cognitive deficits in brain tumour patients: current status and future directions. Curr Opin Oncol. 2019;31:540–7.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Gehring K, Sitskoorn MM, Gundy CM, et al. Cognitive rehabilitation in patients with gliomas: a randomized, controlled trial. J Clin Oncol. 2009;27:3712–22.

    Article  PubMed  Google Scholar 

  30. Hassler MR, Elandt K, Preusser M, Lehrner J, Binder P, Dieckmann K, Rottenfusser A, Marosi C. Neurocognitive training in patients with high-grade glioma: a pilot study. J Neurooncol. 2010;97:109–15.

    Article  PubMed  Google Scholar 

  31. Zucchella C, Capone A, Codella V, de Nunzio AM, Vecchione C, Sandrini G, Pace A, Pierelli F, Bartolo M. Cognitive rehabilitation for early post-surgery inpatients affected by primary brain tumor: a randomized, controlled trial. J Neurooncol. 2013;114:93–100.

    Article  CAS  PubMed  Google Scholar 

  32. Nickell M, Statkus D, Escobar N, Wesling M, Brady S, Jensen M. Dysphagia outcomes in patients with brain tumors undergoing inpatient rehabilitation. Dysphagia. 2003;18:203–10.

    Article  PubMed  Google Scholar 

  33. Asher A, Fu JB, Bailey C, Hughes JK. Fatigue among patients with brain tumors. CNS Oncol. 2016;5:91–100.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Berger AM, Mooney K, Alvarez-Perez A, et al. Cancer-related fatigue, version 2.2015. J Natl Compr Cancer Netw. 2015;13:1012–39.

    Article  Google Scholar 

  35. Armstrong TS, Gilbert MR. Practical strategies for management of fatigue and sleep disorders in people with brain tumors. Neuro Oncol. 2012;14:iv65–72.

    PubMed  PubMed Central  Google Scholar 

  36. Chen C-H, Sheu J-J, Lin Y-C, Lin H-C. Association of migraines with brain tumors: a nationwide population-based study. J Headache Pain. 2018. https://doi.org/10.1186/s10194-018-0944-1.

    Article  PubMed  PubMed Central  Google Scholar 

  37. Forsyth PA, Posner JB. Headaches in patients with brain tumors: a study of 111 patients. Neurology. 1993;43:1678–1678.

    Article  CAS  PubMed  Google Scholar 

  38. Lovely MP. Symptom management of brain tumor patients. Semin Oncol Nurs. 2004;20:273–83.

    Article  PubMed  Google Scholar 

  39. Englot DJ, Chang EF, Vecht CJ. Epilepsy and brain tumors. Handb Clin Neurol. 2016;134:267–85.

    Article  PubMed  PubMed Central  Google Scholar 

  40. Vecht CJ, Kerkhof M, Duran-Pena A. Seizure prognosis in brain tumors: new insights and evidence-based management. Oncologist. 2014;19:751–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  41. Sherman JH, Moldovan K, Yeoh HK, Starke RM, Pouratian N, Shaffrey ME, Schiff D. Impact of temozolomide chemotherapy on seizure frequency in patients with low-grade gliomas. J Neurosurg. 2011;114:1617–21.

    Article  PubMed  Google Scholar 

  42. Koekkoek JAF, Dirven L, Heimans JJ, Postma TJ, Vos MJ, Reijneveld JC, Taphoorn MJB. Seizure reduction is a prognostic marker in low-grade glioma patients treated with temozolomide. J Neurooncol. 2016;126:347–54.

    Article  CAS  PubMed  Google Scholar 

  43. Greenhalgh J, Weston J, Dundar Y, Nevitt SJ, Marson AG. Antiepileptic drugs as prophylaxis for postcraniotomy seizures. Cochrane Database Syst Rev. 2020. https://doi.org/10.1002/14651858.CD007286.pub5.

    Article  PubMed  PubMed Central  Google Scholar 

  44. Tremont-Lukats IW, Ratilal BO, Armstrong T, Gilbert MR. Antiepileptic drugs for preventing seizures in people with brain tumors. Cochrane Database Syst Rev. 2008. https://doi.org/10.1002/14651858.CD004424.pub2.

    Article  PubMed  PubMed Central  Google Scholar 

  45. Mikkelsen T, Paleologos NA, Robinson PD, et al. The role of prophylactic anticonvulsants in the management of brain metastases: a systematic review and evidence-based clinical practice guideline. J Neurooncol. 2010;96:97–102.

    Article  PubMed  Google Scholar 

  46. Forsyth PA, Weaver S, Fulton D, Brasher PMA, Sutherland G, Stewart D, Hagen NA, Barnes P, Cairncross JG, DeAngelis LM. Prophylactic anticonvulsants in patients with brain tumour. Can J Neurol Sci. 2003;30:106–12.

    Article  PubMed  Google Scholar 

  47. Sughrue ME, Rutkowski MJ, Chang EF, Shangari G, Kane AJ, McDermott MW, Berger MS, Parsa AT. Postoperative seizures following the resection of convexity meningiomas: are prophylactic anticonvulsants indicated? J Neurosurg. 2011;114:705–9.

    Article  PubMed  Google Scholar 

  48. Dewan MC, Thompson RC, Kalkanis SN, Barker FG, Hadjipanayis CG. Prophylactic antiepileptic drug administration following brain tumor resection: results of a recent AANS/CNS Section on Tumors survey. J Neurosurg. 2016;126:1772–8.

    Article  PubMed  Google Scholar 

  49. Rooney AG, Carson A, Grant R. Depression in cerebral glioma patients: a systematic review of observational studies. J Natl Cancer Inst. 2011;103:61–76.

    Article  PubMed  Google Scholar 

  50. Rooney AG, McNamara S, Mackinnon M, Fraser M, Rampling R, Carson A, Grant R. Frequency, clinical associations, and longitudinal course of major depressive disorder in adults with cerebral glioma. J Clin Oncol. 2011;29:4307–12.

    Article  PubMed  Google Scholar 

  51. Litofsky NS, Farace E, Anderson F, Meyers CA, Huang W, Laws ER. Depression in patients with high-grade glioma: results of the Glioma Outcomes Project. Neurosurgery. 2004;54:358–67.

    Article  PubMed  Google Scholar 

  52. Mugge L, Mansour TR, Crippen M, Alam Y, Schroeder J. Depression and glioblastoma, complicated concomitant diseases: a systemic review of published literature. Neurosurg Rev. 2020;43:497–511.

    Article  PubMed  Google Scholar 

  53. Pilling S, Anderson I, Goldberg D, Meader N, Taylor C. Depression in adults, including those with a chronic physical health problem: summary of NICE guidance. BMJ. 2009;339:b4108–b4108.

    Article  PubMed  PubMed Central  Google Scholar 

  54. Hart SL, Hoyt MA, Diefenbach M, et al. Meta-analysis of efficacy of interventions for elevated depressive symptoms in adults diagnosed with cancer. J Natl Cancer Inst. 2012;104:990–1004.

    Article  PubMed  PubMed Central  Google Scholar 

  55. Thakkar P, Greenwald B, Patel P. Rehabilitation of adult patients with primary brain tumors: a narrative review. Brain Sci. 2020;10:492.

    Article  CAS  PubMed Central  Google Scholar 

  56. Rooney A, Grant R. Pharmacological treatment of depression in patients with a primary brain tumour. Cochrane Database Syst Rev. 2010. https://doi.org/10.1002/14651858.CD006932.pub2.

    Article  PubMed  Google Scholar 

  57. Beevers Z, Hussain S, Boele FW, Rooney AG. Pharmacological treatment of depression in people with a primary brain tumour. Cochrane Database Syst Rev. 2020. https://doi.org/10.1002/14651858.CD006932.pub4.

    Article  PubMed  PubMed Central  Google Scholar 

  58. Caudill JS, Brown PD, Cerhan JH, Rummans TA. Selective serotonin reuptake inhibitors, glioblastoma multiforme, and impact on toxicities and overall survival. Am J Clin Oncol. 2011;34:385–7.

    Article  CAS  PubMed  Google Scholar 

  59. Boele F, Rooney A, Grant R, Klein M. Psychiatric symptoms in glioma patients: from diagnosis to management. Neuropsychiatr Dis Treat. 2015;11:1413–20.

    Article  PubMed  PubMed Central  Google Scholar 

  60. Chambers SK, Grassi L, Hyde MK, Holland J, Dunn J. Integrating psychosocial care into neuro-oncology: challenges and strategies. Front Oncol. 2015. https://doi.org/10.3389/fonc.2015.00041.

    Article  PubMed  PubMed Central  Google Scholar 

  61. Gregg N, Arber A, Ashkan K, Brazil L, Bhangoo R, Beaney R, Gullan R, Hurwitz V, Costello A, Yágüez L. Neurobehavioural changes in patients following brain tumour: patients and relatives perspective. Support Care Cancer. 2014;22:2965–72.

    Article  CAS  PubMed  Google Scholar 

  62. Holland J, Watson M, Dunn J. The IPOS new international standard of quality cancer care: integrating the psychosocial domain into routine care. Psychooncology. 2011;20:677–80.

    Article  PubMed  Google Scholar 

  63. •Yu J, Jung Y, Park J, Kim JM, Suh M, Cho KG, Kim M. Intensive rehabilitation therapy following brain tumor surgery: a pilot study of effectiveness and long-term satisfaction. Ann Rehabil Med. 2019;43:129–41. Study found improved functional outcomes and caregiver satisfaction in patients following brain surgery for primary brain tumors.

    Article  PubMed  PubMed Central  Google Scholar 

  64. Bartolo M, Zucchella C, Pace A, et al. Early rehabilitation after surgery improves functional outcome in inpatients with brain tumours. J Neurooncol. 2012;107:537–44.

    Article  PubMed  Google Scholar 

  65. Huang ME, Cifu DX, Keyser-Marcus L. Functional outcomes in patients with brain tumor after inpatient rehabilitation. Am J Phys Med Rehabil. 2000;79:327–35.

    Article  CAS  PubMed  Google Scholar 

  66. Kirshblum S, O’Dell MW, Ho C, Barr K. Rehabilitation of persons with central nervous system tumors. Cancer. 2001;92(4 Suppl):1029–38. https://doi.org/10.1002/1097-0142(20010815)92:4+<1029::aid-cncr1416>3.0.co;2-p.

  67. Khan F, Amatya B, Drummond K, Galea M. Effectiveness of integrated multidisciplinary rehabilitation in primary brain cancer survivors in an Australian community cohort: a controlled clinical trial. J Rehabil Med. 2014;46:754–60.

    Article  PubMed  Google Scholar 

  68. •Shahpar S, Wong AWK, Keeshin S, Eickmeyer SM, Semik P, Kocherginsky M, McCarty S. Functional outcomes of an interdisciplinary outpatient rehabilitation program for patients with malignant brain tumors. PM&R. 2018;10:926–33. Study assesses the effect of outpatient rehabilitation in patients with primary brain tumors.

    Article  Google Scholar 

  69. Ostrom QT, Patil N, Cioffi G, Waite K, Kruchko C, Barnholtz-Sloan JS. CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2013–2017. Neuro Oncol. 2020;22:v1–96.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. MossRehab Drucker Brain Injury Unit, 60 Township Line Rd, Elkins Park, PA, 19027, USA

    Jaclýn Barcikowski

Authors
  1. Jaclýn Barcikowski
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jaclýn Barcikowski.

Ethics declarations

Conflict of Interest

The author declares no competing interests.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by the author.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article is part of the Topical Collection on Brain Injury Medicine and Rehabilitation

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Barcikowski, J. Rehabilitation of Adult Patients with Primary Brain Tumors. Curr Phys Med Rehabil Rep 10, 106–113 (2022). https://doi.org/10.1007/s40141-022-00345-8

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40141-022-00345-8

Keywords

Search

Navigation